Page 324

111. Waisman A, Ruiz PJ, Hirschberg DL, et al. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med.; 2: 899-905.

112. Warrington AE, Asakura K, Bieber AJ, et al. 2000. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A.; 97: 6820-6825.

113. Waubant E, Goodkin D. 2000. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis. Pathol Biol (Paris).; 48: 104-13.

114. Webster HD. 1997. Growth factors and myelin regeneration in multiple sclerosis. Mult Scler.; 3: 113-20.

115. Wicker LS, Miller BJ, Chai A, Terada M, Mullen Y. 1988. Expression of genetically dete mined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice. J Exp Med.; 167: 1801-10.

116. Wilson DB, Golding AB, Smith RA, et al. 1997. Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations. J Neuroimmunol.; 76: 15-28.

117. Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB. 1995. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol.; 134: 261-72.

118. Yandava BD, Billinghurst LL, Snyder EY. 1999. “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A.; 96: 7029-34.

119. Ye P, D'Ercole AJ. 1999. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology.; 140: 3063-72.

120. Zhang J, Stinissen P, Medaer R, Truyen L, Raus J. T-cell vaccination for the treatment of multiple sclerosis. In Zhang J, ed. Immunotherapy in Neuroimmunologic Diseases. London, England: Martin Dunitz; 1998.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement